Announcement

Collapse
No announcement yet.

Hong Kong (PRC SAR): Pandemic Influenza H1N1 2009, Vaccines, vaccinations: news archive (until January 31, 2010)

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Hong Kong (PRC SAR): Pandemic Influenza H1N1 2009, Vaccines, vaccinations: news archive (until January 31, 2010)

    Hong Kong: Government announces details of human swine influenza vaccination programme (with video) (11/30/09)

    A spokesman for the Food and Health Bureau announced today (November 30) that the Government would launch the human swine influenza vaccination programme on December 21.

    Under the programme, about two million people falling under the five target groups - chronic patients and pregnant women, children aged from six months to under six years, elderly aged 65 and above, healthcare workers and workers in the pig industry - will be given priority to receive vaccinations on a voluntary base.

    "The hospitals, clinics and medical centres under the Department of Health and Hospital Authority (HA) will provide free vaccination service to the target groups. From December 28, three of the five target groups can choose to vaccinate at private clinics on government subsidy. This arrangement is meant to provide more choices to them," the spokesman said.

    The three target groups are chronic patients and pregnant women, children aged from six months to under six years and the elderly aged 65 and above. They can opt to receive the vaccination from private doctors who have joined the human swine influenza vaccination subsidy scheme. The Government will subsidise them an amount of $129, including $79 per dose for the vaccine cost and $50 for the injection fee. Information including the addresses of the private clinics which have taken part in the subsidy scheme and any additional fees charged will be uploaded to the website of the Centre for Health Protection of the Department of Health (http://www.chp.gov.hk) for public reference.

    Participating doctors are also required to display logos of the scheme for easy recognition.

    "We encourage the target groups to receive the vaccination where they normally go for medical services," the spokesman said.

    For the remaining two target groups, healthcare workers can receive vaccination from their serving medical institutions or HA clinics, while workers in the pig industry can get free vaccinations from HA's designated clinics.

    "Human swine flu cases continue to be found all over the world and the situation in Hong Kong may become more serious with the arrival of the winter influenza peak.

    People belonging to the target groups are urged to be vaccinated to reduce the chance of infection and safeguard their health," the spokesman said. "Although there are reports of feeling unwell after the human swine flu vaccination, abnormality has so far not been found. Receiving vaccination is still safe and that members of the public should not be over-worried," the spokesman said. "We believe that the first batch of 500,000 dosages will be sufficient to meet the initial demand of the target groups. The remaining 2.5 million dosages will arrive in January next year. People who are not in the target groups can choose to receive vaccination from private clinics on their own cost after the second batch of vaccines arrives," he said.
    -

    View Original Article

  • #2
    Re: Hong Kong: Government announces details of human swine influenza vaccination programme (with video) (11/30/09)

    Hong Kong: HA gets ready for Government Human Swine Influenza Vaccination Programme (11/30/09)

    The following is issued on behalf of the Hospital Authority:

    To tie in with the Government's human swine influenza (HSI) vaccination programme, the Hospital Authority (HA) will start to provide free vaccinations to the target groups of Hong Kong residents from 21 December 2009 at public hospitals and clinics.

    The HA spokesman today (Monday, 30 November) said that the following target groups will receive HSI vaccinations in public hospitals and clinics:
    1. All chronic patients who are regularly followed up at HA general outpatient and specialist clinics (chronic illnesses include cardiovascular [except hypertension without complication] and lung disease; obesity or metabolic or kidney disease; immunodeficiency; chronic neurological condition; children and adolescents [aged six-month to 18-year-old] on long-term aspirin therapy);
    2. All pregnant women with antenatal appointments in HA obstetric clinics;
    3. Elderly aged 65 or above; and
    4. Chronic patients aged below 65 who do not attend HA clinics but with referral from the Department of Health.


    The chronic patients and pregnant women of public hospitals who wish to receive vaccination service should attend the general outpatient clinics or specialist clinics and bring along relevant documents, including Hong Kong Identity Card and appointment slip.

    They will be vaccinated if assessed as clinically suitable by clinic staff.

    For all elderly aged 65 or above and those chronic patients aged below 65 but not HA patients and with referral from Department of Health, they would be able to receive vaccination service in the 61 general outpatient clinics under HA. Furthermore, workers in the pig industry and healthcare workers as referred by the Department of Health will also receive HSI vaccinations in the 18 designated general outpatient clinics of HA from 21 December 2009.

    The HA spokesman stresses that the HSI vaccine is safe.

    "Protection from HSI vaccination develops about two weeks after getting a shot. The side effects are similar to those of seasonal flu vaccination. It is usually well tolerated apart from occasional soreness at the injection site. In rare instances, the recipient may experience fever, muscle and joint pains, and tiredness beginning six to 12 hours after vaccination and lasting up to two days."

    "People who have flu symptoms, fever or are severely ill at the time of vaccination should defer the vaccination and wait until they have recovered. Patients can enquire at the respective specialist or general out-patient clinics where they are attending; or make general enquiry at the HA hotline 2300 6555 during office hours," the spokesman remarked.
    -

    View Original Article

    Comment


    • #3
      Hong Kong: SFH on US recall of swine flu vaccine (12/16/09)

      Hong Kong: SFH on US recall of swine flu vaccine (12/16/09)

      Following is the transcript of remarks (English portion) made by the Secretary for Food and Health, Dr York Chow, at a stand-up media session before attending a Legislative Council meeting today (December 16):

      Reporter:
      Will Hong Kong have any corresponding measures now that the United States has ordered a recall of the swine flu vaccine ?

      Secretary for Food and Health:
      First of all, I think the product recalled in the United States is very different from the one ordered by Hong Kong, although it is produced by the same vaccine company. But this is actually a world-wide company. It has many factories and this product is actually produced in the factory in the United States rather than in France. Those we have ordered come from France and has complied entirely with the standards as required. The second thing is relating to the reason for recall. As far as we know, it is related to the decrease in the antigenicity of the vaccine after it has been produced. So I think this is very different from what we have in Hong Kong. This is a single-vial type of preparation and the one in Hong Kong is actually a multi-vial type of preparation. So, it is entirely different and it is quite safe for Hong Kong and also effective for Hong Kong to continue the vaccination programme.

      (Please also refer to the Chinese portion of the transcript.)
      -

      View Original Article

      Comment


      • #4
        Hong Kong: Transcript of CE (Donald Tsang) on human swine influenza vaccination (12/17/09)

        Hong Kong: Transcript of CE on human swine influenza vaccination (12/17/09)

        Following is the transcript of remarks by the Chief Executive, Mr Donald Tsang, at a media session after receiving vaccination against human swine influenza at Sai Wan Ho General Out-patient Clinic today (December 17):

        Chief Executive:
        I've just received the human swine flu vaccination with our Secretaries and also with more than 10 representatives of the medical sector. The whole process was very fast and rather painless. We all know that the human swine flu cases continue to be found all over the world. In Hong Kong, the situation may become more serious with the approach of the winter influenza peak. We have been, as a community, very alert and we have to act fast to safeguard the health of the general public. The Government will launch the human swine flu vaccination programme from December 21. About two million people belonging to the five target groups may receive vaccinations on a voluntary basis and totally free. They include chronic patients, pregnant women, children aged from 6 months to under 6 years, elderly like myself, aged 65 or above - healthcare workers - like York here - and workers in the pig farming industry. I would also say a few words about the US recall of some of the swine flu vaccine.

        The recalled lot in the US consists of "pre-filled syringes" for paediatric use, and that is different from the Hong Kong batch which consists of "multi-dose vials", which, as far as we know, is for 10 injections. The recalled lot is produced in the United States, while ours is from France. The Department of Health has checked the specification and the batch certificates very carefully and they conform totally with our potency specifications. Also, the manufacturer of our vaccine, Sanofi Pasteur, is the largest vaccine manufacturer in the world. They are responsible for producing about a quarter of the total global production. More than two million patients in Europe have been vaccinated with exactly the same vaccine that I received earlier today. The reaction is generally very mild and is very safe. There is no need for people to be worried. I would encourage those in the five at-risk groups to receive the vaccination as quickly as possible. This is not only for their own sake and for the sake of other people who are in close contact with them.

        (Please also refer to the Chinese portion of the transcript.)
        -

        View Original Article

        Comment


        • #5
          Hong Kong: SFH on human swine flu vaccine (12/17/09)

          Hong Kong: SFH on human swine flu vaccine (12/17/09)

          Following is the transcript of remarks (English portion) made by the Secretary for Food and Health, Dr York Chow, at a stand-up media session after receiving human swine flu vaccination at Sai Wan Ho General Out-patient Clinic today (December 17):

          Reporter:
          (Question on banning Mainland people coming to Hong Kong for vaccination)

          Secretary for Food and Health:
          I don't think we can actually use the word "ban". Actually we have encouraged private doctors and they have agreed that priority be given to Hong Kong patients and particularly in the coming few weeks, i.e. the first few weeks of the (vaccination) campaign, we should focus on giving vaccinations to the high-risk groups.

          Reporter:
          (Question on the safety of vaccine)

          Secretary for Food and Health:
          I think the vaccines have been assessed very carefully by the expert committee of the Centre for Health Protection and it will definitely protect the high-risk groups. The chance for them developing side-effects is much lower than the effects when they actually have influenza and then develop complications resulting perhaps in more severe illnesses or even death. So, I think it is important to remind those in the high-risk groups that they should seek vaccination as soon as possible. The Government has already obtained sufficient number of vaccines for all of them and it is up to them to come forward to receive the vaccination.

          Reporter:
          (Question on the safety of vaccine)

          Secretary for Food and Health:
          Of course, they would take the risk that in case they have influenza, they will have higher risk of developing complications or may be other eventuality. It is important for them to know about that and this is the reason why we are stepping up publicity in terms of various media announcements and so on. I hope that members of the public would know that this is a measure to protect them and their family members.

          Reporter:
          (Question on consent form)

          Secretary for Food and Health:
          The consent form's purpose is mainly to ensure that the patients who receive the vaccination have been informed of the effects as well as the possible side-effects of the vaccine. It does not mean that with signatures on the form, they cannot seek any type of action in order to claim for compensation. It depends on the situation and what types of side-effects they have. We will investigate all side-effects especially for the significant ones, to see whether they are related to the vaccination.

          Reporter:
          (Question on H1N1 virus detected in pigs)

          Secretary for Food and Health:
          As the experts have already mentioned, it is not surprising to find H1N1 virus in pigs nowadays because it is easily transmissible between pigs and between human and pigs. It is important to discover whether there are large-scale of infection among pigs or whether there are large scale transmission between human and pigs. So far, we have not actually detected this through the regular surveillance that we have carried out in the abattoirs. We have already informed the Mainland authorities regarding the findings and they will investigate whether the two farms that are exporting pigs to Hong Kong have any particular irregularities within the pig farmers and the pigs. So far, they have not discovered anything.

          (Please also refer to the Chinese portion of the transcript.)
          -

          View Original Article

          Comment


          • #6
            Re: Hong Kong: SFH on human swine flu vaccine (12/17/09)

            Hong Kong: Acting SFH on human swine influenza vaccine (12/21/09)

            Following is the transcript of remarks (English portion) made by the Acting Secretary for Food and Health, Professor Gabriel Leung, at a stand-up media session after visiting Chai Wan Health Centre today (December 21):

            Reporter:
            (Question on the monitor of the use of the vaccine)

            Acting Secretary for Food and Health:
            We have a system to monitor the use of human swine flu vaccine in the private sector as well as those in our own public clinics, and we would be able to tell from the statistics, the proportion allocated to the target groups versus those who do not fall under those five categories (target groups). If we have seen substantial deviation in the ratios, we will of course put a close watch on the cases. In the contracts between us and the private practitioners, there is of course a clause stating that they must abide by the guidelines and rules, or the contracts between us may be suspended in serious cases.

            Reporter:
            (Question on response to the vaccination programme)

            Acting Secretary for Food and Health:
            I think the important thing is, first of all, a lot of schools are still going on today and therefore I can understand why it may be a little bit difficult to have the kids in the clinic to get vaccinated. Secondly, I think it is important to note that we have adjusted our strategy in that we no longer require people to make an appointment first and that makes it easier and convenient for parents and guardians to take children to our clinics. Of course, the caveat is: subject to the availability of the slots, but I think the important thing is to encourage more children under the age of six to come out and get vaccinated and protected before the winter peak comes along.

            (Please also refer to the Chinese portion of the transcript.)
            -

            View Original Article

            Comment


            • #7
              Hong Kong: Centre for Health Protection investigates suspected limb weakness Guillaine-Barr? Syndrome compatible (with updates)

              Hong Kong: Centre for Health Protection investigates suspected limb weakness case following HSI vaccination (1/6/10)

              The CHP is investigating the case of a 58-year-old man admitted to Queen Mary Hospital who complained about lower limb weakness following human swine influenza (HSI) vaccination.

              The Expert Group on serious adverse events following HSI vaccination will meet tomorrow to discuss the case.
              -

              View Original Article

              Comment


              • #8
                Re: Hong Kong: Centre for Health Protection investigates suspected limb weakness case following HSI vaccination (1/6/10)

                Hong Kong: Centre for Health Protection investigates suspected limb weakness case following HSI vaccination (1/6/10)

                The Department of Health's Centre forHealth Protection (CHP) has provided updated information regarding its investigation intothe case of a 58-year-old man admitted to Queen Mary Hospital who complained about lower limb weakness following human swine influenza (HSI)vaccination.

                The patient received HSI vaccination on December 24, 2009.

                He developed bilateral lower limb weakness for about one week before admission to hospital on January 2, 2010.

                The patient is now listed in serious condition, but his vital signs are stable.

                The Expert Group on serious adverse events following HSI vaccination will meet at CHP tomorrow around noon to discuss the case.

                The group comprises clinicians, microbiologists, neurologists and epidemologists.
                -

                View Original Article

                Comment


                • #9
                  Re: Hong Kong: Centre for Health Protection investigates suspected limb weakness case following HSI vaccination (1/6/10)

                  Hong Kong: Meeting of Expert Group on Serious Adverse Events following Vaccination (1/7/10)

                  Members of the Expert Group on Serious Adverse Events following Human Swine Influenza (HSI) Vaccination met today (January 7) to discuss the case of a 58-year-old man admitted to Queen Mary Hospital (QMH) who complained about lower limb weakness after HSI vaccination.

                  The Expert Group concluded that the clinical features of the patient were compatible with Guillain-Barre Syndrome (GBS).

                  Further tests were being conducted to ascertain the final diagnosis.

                  "The group considered that it was not possible to differentiate with reasonable certainty whether the relationship between HSI vaccination and the patient's symptoms was causal or coincidental, i.e, by chance," a spokesman for the Expert Group said.

                  The spokesman also noted that to date, the World Health Organisation (WHO) had found no evidence suggesting a causal relationship between GBS and HSI vaccination, and the number of GBS worldwide was in line with normal background rates of this illness.

                  The group recommended that the Department of Health's Centre for Health Protection (CHP) should closely monitor the local and global situation.

                  The spokesman added that over 80 million doses of HSI vaccines had been administered worldwide.

                  To date, overseas reports on adverse events following HSI vaccination do not suggest human swine influenza vaccine is associated with an increased risk of GBS.

                  The WHO asserts that the number of GBS worldwide is in line with normal background rates of this illness.

                  Locally, between 42 and 65 cases of GBS are recorded each year based on Hospital Authority data from 2000 to 2009, irrespective of vaccination history, with more cases occurring during the winter period.

                  The spokesman said that from a population perspective, no association between HSI vaccination and GBS could be established at this point, but rare idiosyncratic response of an individual to any vaccines or drugs could not be excluded.

                  The Government's HSI vaccination programme will continue.

                  The CHP received report about the case on January 6, 2010.

                  The patient received HSI vaccination on December 24, 2009. He developed bilateral calf pain and increasing lower limb weakness since December 28, 2009 and was admitted to QMH on January 2, 2010. His condition is currently listed as serious but his vital signs are stable.
                  -

                  View Original Article

                  Comment


                  • #10
                    Re: Hong Kong: Centre for Health Protection investigates suspected limb weakness Guillaine-Barr? Syndrome compatible (with updates)

                    Hong Kong: PMH's Response on a case of limb weakness following HSI vaccination (1/13/10)

                    The following is issued on behalf of the Hospital Authority:

                    In response to media enquiry, the spokesperson of Princess Margaret Hospital (PMH) gave the following reply today (January 13):

                    A 91-year-old male patient, who received seasonal influenza vaccine on November 26 last year and human swine influenza vaccine on January 4 from a private doctor, presented with back pain, lower limb weakness, cough and flu symptoms and was admitted to the Medicine and Geriatrics Ward via the Accident & Emergency Department on January 12. He is in stable condition and being examined and assessed by neurologists.

                    The case has been reported to the Centre for Health Protection and the Hospital Authority Head Office according to established guidelines. The hospital is closely monitoring his condition.
                    -

                    View Original Article

                    Comment


                    • #11
                      Re: Hong Kong: Centre for Health Protection investigates suspected limb weakness Guillaine-Barr? Syndrome compatible (with updates)

                      Hong Kong: CHP is investigating a case of limb weakness following HSI vaccination (1/13/10)

                      The Centre for Health Protection (CHP) of the Department of Health today (January 13) received a report involving a 91-year-old patient admitted to Princess Margaret Hospital who complained about lower limb weakness following human swine influenza (HSI) vaccination.

                      His current condition is stable and his past health is unremarkable.

                      CHP's investigation showed that the patient developed cough on January 8. He also complained of bilateral lower limb weakness on January 9 and was admitted to the hospital on January 12. The patient had a history of receiving HSI vaccination in a private clinic on January 4.

                      "The patient was assessed by neurologist. Clinical assessment showed that he had decrease in power in both legs.

                      "The nerve conduction test conducted this afternoon revealed normal finding," a spokesman for CHP said.

                      Further tests, including examination of cerebrospinal fluid (CSF) and magnetic resonance imaging, to assess whether his symptoms are due to Guillain-Barre Syndrome (GBS) or other causes, are pending.

                      "It is noticed that in the previous 58-year old GBS compatible patient, his nerve conduction test showed prolonged distal motor latency, which was compatible with early phase of GBS and other demyelinating diseases, and his CSF showed high protein content.

                      "At this point, a definitive diagnosis of GBS cannot be established for the 91-year-old patient. CHP will closely monitor the clinical progress and further laboratory results of this patient, and convene an Expert Group meeting if further supportive evidence of GBS is available," the spokesman said.
                      -

                      View Original Article

                      Comment


                      • #12
                        Hong Kong: CHP investigates case of limb weakness following HSI vaccination (1/18/10)

                        Hong Kong: CHP investigates case of limb weakness following HSI vaccination (1/18/10)

                        The Centre for Health Protection (CHP) of the Department of Health today (January 18) received report about a 67-year-old woman admitted to Kwong Wah Hospital who complained about limb weakness following human swine influenza (HSI) vaccination.

                        The patient was staying in the Intensive Care Unit in critical condition.

                        CHP's investigation showed that the patient complained of generalized weakness on January 12. She developed fever, headache and vomiting on January 15 and was admitted to the hospital on the same day. She received HSI vaccination on December 23, 2009.

                        "The patient has normal protein content in the cerebrospinal fluid (CSF) and the nerve conduction study was inconclusive. She has a high white blood cell count in her blood," the spokesman said.

                        "Further investigations are being conducted to determine whether she has sepsis, autonomic neuropathy, Guillain-Barre Syndrome (GBS) or other conditions."

                        It is noted that the previous 58-year-old GBS compatible patient in Queen Mary Hospital had no fever. His nerve conduction test showed prolonged distal motor latency in the foot muscles and his CSF showed high protein content. All of them are signs compatible with the early phase of GBS and other demyelinating diseases.

                        "At this point, a definitive diagnosis of GBS cannot be established for the 67-year-old woman. CHP will closely monitor the clinical progress and further laboratory results of this patient and convene an Expert Group meeting if further supportive evidence of GBS is available? the spokesman said.
                        -

                        View Original Article

                        Comment


                        • #13
                          Hong Kong: SFH on human swine influenza vaccine [and GBS suspected cases] (1/20/10)

                          Hong Kong: SFH on human swine influenza vaccine (1/20/10)

                          Following is the transcript of remarks (English portion) made by the Secretary for Food and Health, Dr York Chow, at a media stand-up session at the Legislative Council Building today (January 20):

                          Reporter:
                          The private doctor who had symptoms of GBS has been discharged from hospital. Do you know whether it is GBS that is directly related to swine flu vaccine?

                          Secretary for Food and Health:
                          I think his diagnosis is quite certain as Guillain-Barr? syndrome (GBS), but it is very difficult to determine whether this has a direct relation as a result of the vaccination, or whether this is a result of other types of so-called stimulation of agent. In fact, the Centre for Health Protection has given the case summary to some international experts to seek their opinion on that. But I am really happy that he (the patient) has recovered so quickly and more or less completely within two weeks. This is a good sign that the treatment given to him is very effective.

                          Reporter:
                          What about the second suspected case?

                          Secretary for Food and Health:
                          There is quite a number of so-called suspected cases, but none of them has now been put on the (list of) so-called confirmed Guillain-Barr? syndrome cases. They are all suspected cases. In fact, as far as the vaccination programme shows, at this moment the only possible complication or side-effect is related to the first patient. All the other subsequent patients have not been put on the list of really confirmed Guillain-Barr? syndrome and also particularly not related to the vaccination.

                          Reporter:
                          Tomorrow will be exactly a month since the vaccination programme started. Considering the low take-up rate, will you consider the vaccination programme as a success?

                          Secretary for Food and Health:
                          I think the vaccination programme is always considered as an insurance, that is, in case of need, we can provide adequate vaccine for all the at-risk groups. We have done that. Although the uptake rate is not very high at this moment, this may also be related to the fact that the epidemic in Hong Kong has not been very serious so far. In fact, the various surveillance (data) show that the peak is yet to come. So I think we still have time, in case when the peak is approaching, we are able to encourage more people to take up the vaccine. But at this moment, I am not particularly that worried.

                          Reporter:
                          (about the number of vaccines)

                          Secretary for Food and Health:
                          We have already bought three million doses and that is it.

                          Reporter:
                          (about vaccine)

                          Secretary for Food and Health:
                          We have taken into account that there are two influenza peaks in Hong Kong. One is the winter season peak which usually appears in February and March. And so far we do not see any surge indicating this peak from our surveillance. The second peak will be around July and August. That is also the same time when we had the very prolonged peak in 2009. In other words, the vaccine can protect people from these two peaks in the coming year. And that is why we are not too worried about the utilisation of vaccine at this stage, because if the second peak, that is the winter peak, is not to come, we still need to protect people from the summer peak. That is also another concern we have. We are not going to give up the three million doses to anybody. We are going to keep it as a safeguard for our community. We do not see the need of buying any more at the moment because we can foresee that a number of percentage of our community has already been immunised at this stage. So I think the three million doses will be adequate for the coming year. Regarding the winter peak or winter influenza for 2011, as far as I know, the new vaccine will be incorporated into the seasonal influenza vaccine at the end of this year. We will be purchasing the seasonal influenza vaccine in the same way as in previous years.

                          Reporter:
                          How soon will we know when the Government is going to expand the vaccination programme to non-target groups?

                          Secretary for Food and Health:
                          In fact, the private sector has already been vaccinating people not belonging to target groups, but they have to pay for their own vaccine. That has been done. We will allow this to happen because there is difference in opinions, there are still people who like to be vaccinated. I think we have adequate vaccine to allow the private sector to utilise the vaccine that we have.

                          (Please also refer to the Chinese portion of the transcript)
                          -

                          View Original Article

                          Comment


                          • #14
                            Hong Kong: CHP investigates case of intrauterine death (1/20/10)

                            Hong Kong: CHP investigates case of intrauterine death (1/20/10)

                            The Centre for Health Protection (CHP) of the Department of Health, through a surveillance system established since the launch of the human swine influenza (HSI) vaccination programme, today (January 20) received a report about a case of intrauterine death (IUD) involving a 37-year-old pregnant woman.

                            The woman is now staying at Tuen Mun Hospital (TMH) in stable condition.

                            The CHP's investigation showed that the woman at 28 weeks of gestation was suffering from a medical condition and was on regular medications.

                            She was monitored at TMH and a Maternal and Child Health Centre (MCHC) during her pregnancy. An examination performed at the MCHC on January 5 was normal.

                            On January 19, she reported decreased foetal movement and no foetal heart sound could be detected when she attended the MCHC. She was referred and admitted to TMH and intrauterine death was confirmed. She had received an HSI vaccination at the MCHC on December 28, 2009. Investigations for common causes of intrauterine death, including infection, genetic and metabolic disorders, are being carried out.

                            In Hong Kong, about 150 to 220 stillbirths are recorded every year.

                            A CHP spokesman said that there is no medical evidence presently to suggest that the intrauterine death was related to the HSI vaccination.

                            According to the World Health Organisation, studies to date do not show harmful effects from the HSI vaccine with respect to pregnancy or a developing embryo or foetus.

                            On the other hand, the chances of HSI-infected pregnant women requiring hospitalisation in intensive care units are 10 times higher than those of infected persons in the general population and the benefits of vaccination far outweigh the risks.

                            Cases of IUD following an HSI vaccination have also been recorded and monitored in overseas countries.

                            So far no causal relationship has been found between an HSI vaccination and IUD. The CHP will closely monitor the clinical progress and further laboratory results of this woman.
                            -

                            View Original Article

                            Comment


                            • #15
                              Hong Kong: Kwong Wah Hospital response on condition of patient with limb weakness (1/20/10)

                              Hong Kong: Kwong Wah Hospital response on condition of patient with limb weakness (1/20/10)

                              The following is issued on behalf of the Hospital Authority:

                              In response to a media enquiry, the spokesperson of Kwong Wah Hospital (KWH) gave the following reply today (January 20):

                              A 67-year-old female patient with generalised weakness, fever, headache and vomiting was admitted to the hospital for treatment last Friday (January 15).

                              According to the latest review of her clinical condition by a neurologist, all findings do not indicate Guillain-Barre Syndrome (GBS).

                              The patient has been classified as a"non-GBS" case. She is now in critical condition and is being treated in the intensive care unit. The hospital will closely monitor her condition and provide appropriate treatment.
                              -

                              View Original Article

                              Comment

                              Working...
                              X